Radiation Protection, Dosimetry, and Radiobiology — WACS Viva & Clinical Scenarios (Radiological Physics, Equipment, and Radiation Safety)

Exam-style radiation protection, dosimetry, and radiobiology viva scenarios with examiner probes and model answers for Radiology candidates.

Scenarios covered

• SCENARIO 1: Explain the molecular and cellular mechanisms of radiation-induced biological damage, contrasting direct and indirect ionizing actions, free radical radiolysis of water, and DNA repair pathways. Differentiate deterministic tissue reactions from stochastic effects, incorporating cell cycle radiosensitivity, the Law of Bergonie and Tribondeau, and the Linear No-Threshold (LNT) model.
• SCENARIO 2: Define absorbed dose, equivalent dose, and effective dose, stating their modern SI units, radiation weighting factors (wR), and tissue weighting factors (wT). Explain how air kerma, kerma area product (KAP / DAP), and entrance surface dose (ESD) are measured, monitored, and applied to clinical dosimetry during fluoroscopy and computed tomography.
• SCENARIO 3: Discuss the core tenets of the International Commission on Radiological Protection (ICRP) framework: Justification of practice, Optimization of protection (ALARA / ALARP), and Application of dose limits. Detail the statutory annual dose limits for occupational workers, pregnant radiation workers, and members of the public according to regional West African regulatory standards.
• SCENARIO 4: Describe the physical principles, operational mechanisms, advantages, and limitations of personal radiation monitoring devices, specifically comparing Thermoluminescent Dosimeters (TLD), Optically Stimulated Luminescence (OSL) dosimeters, and electronic direct-reading dosimeters. Detail the regulatory audit and action pathway triggered by an unexpected high personal dosimetry reading.
• SCENARIO 5: Formulate an evidence-based clinical and radiological management protocol for a pregnant patient requiring emergent imaging for suspected life-threatening pulmonary embolism or acute polytrauma. Discuss gestational stage vulnerabilities, fetal threshold doses for teratogenesis, mental retardation, and childhood carcinogenesis, and specific modality selection strategies.